HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A J Peeters Selected Research

Anti-Citrullinated Protein Antibodies

2/2012Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A J Peeters Research Topics

Disease

5Rheumatoid Arthritis
02/2012 - 02/2008
2Congenital Abnormalities (Deformity)
12/2010 - 08/2009
1Pain (Aches)
02/2012
1Osteoporosis
11/2007
1Carcinoma (Carcinomatosis)
06/2003

Drug/Important Bio-Agent (IBA)

2Rheumatoid FactorIBA
02/2012 - 11/2007
2SilverIBA
12/2010 - 08/2009
1Anti-Citrullinated Protein AntibodiesIBA
02/2012
1cyclic citrullinated peptideIBA
02/2012
1ametantrone (HAQ)IBA
02/2012
1AntibodiesIBA
02/2012
1amsonic acid (DAS)IBA
02/2008

Therapy/Procedure

2Splints (Splint)
12/2010 - 08/2009
1Therapeutics
02/2012
1Self-Help Devices (Assistive Technology)
02/2009
1Radiotherapy
06/2003
1Gas Lasers
06/2003